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Background: Proton currents are required for optimal respiratory burst in phagocytes. Recently, HVCN1 was
identified as the molecule required for the voltage-gated proton channel activity associated with the respiratory
burst in neutrophils. Although there are similarities between eosinophils and neutrophils regarding their
mechanism for respiratory burst, the role of proton channels in eosinophil functions has not been fully understood.
Results: In the present study, we first identified the expression of the proton channel HVCN1 in mouse eosinophils.
Furthermore, using HVCN1-deficient eosinophils, we demonstrated important cell-specific effector functions for
HVCN1. Similar to HVCN1-deficient neutrophils, HVCN1-deficient eosinophils produced significantly less reactive
oxygen species (ROS) upon phorbol myristate acetate (PMA) stimulation compared with WT eosinophils. In contrast
to HVCN1-deficient neutrophils, HVCN1-deficient eosinophils did not show impaired calcium mobilization or
migration ability compared with wild-type (WT) cells. Uniquely, HVCN1-deficient eosinophils underwent significantly
increased cell death induced by PMA stimulation compared with WT eosinophils. The increased cell death was
dependent on NADPH oxidase activation, and correlated with the failure of HVCN1-deficient cells to maintain
membrane polarization and intracellular pH in the physiological range upon activation.
Conclusions: Eosinophils require proton channel HVCN1 for optimal ROS generation and prevention of
activation-induced cell death.
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Eosinophils are bone marrow (BM)-derived granulocytes
that are implicated in of numerous inflammatory re-
sponses, especially allergic diseases and parasitic helminth
infections [1]. In response to diverse stimuli, eosinophils
are recruited from the circulation to the inflammatory
foci, where they secrete an array of pro-inflammatory fac-
tors upon activation, including chemokines, cytokines and
reactive oxygen species (ROS). Thus, understanding the
mechanisms regulating eosinophil effector functions may
reveal important implications for eosinophilic inflamma-
tory responses.
ROS generation in eosinophils is dependent on assem-
bly and activation of the normally latent NADPH oxi-
dase complex, which is located in the plasma membrane
and has strong similarities to the NADPH oxidase* Correspondence: Nives.Zimmermann@cchmc.org
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reproduction in any medium, provided the orcomplex in neutrophils [2,3]. Upon activation, the
NADPH oxidase transports electrons across the mem-
brane to reduce molecular oxygen, O2, into superoxide,
O2
- , which undergoes non-enzymatic or superoxide
dismutase (SOD)-catalyzed dismutation to hydrogen
peroxide, H2O2. In turn, hydrogen peroxide can be used
by eosinophil peroxidase or neutrophil myeloperoxidase
to form HOBr or HOCl, respectively [4]. During this
process, the NADPH oxidase is electrogenic and voltage
dependent [5-7], and its sustained production of super-
oxide requires the movement of a compensating charge
across the membrane, i.e. efflux of positively charged
ions or influx of negatively charged ions. Multiple stud-
ies have found that most of the compensating charge is
carried by protons that are released in the cytosol by the
conversion of NADPH to NADP+ and H+ and subse-
quently efflux via voltage-gated proton channels [7].
This efflux of protons simultaneously provides the com-
pensating charge and prevents the acidification of the
cytosol. In 2006, the voltage-gated proton channel was. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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recently, the generation of viable mice bearing a
disrupting mutation within the Hvcn1 gene encoding
the voltage-gated proton channel prompted a wave of
new studies on proton channel function and regulation
[10,11]. A few studies found that phorbol myristate
acetate (PMA)-activated HVCN1-deficient neutrophils
produced less ROS than neutrophils from WT mice
[10,12], which suggests that HVCN1 is required for
high-level NADPH oxidase-dependent superoxide
production during phagocyte respiratory burst. Unex-
pectedly, loss of HVCN1 also decreased neutrophil
migration ability in vitro [12]. Moreover, HVCN1 defi-
ciency in B cells downregulated B cell receptor signaling
and antibody responses in vivo [13]. Taken together,
these findings identified unanticipated and varied
functions for HVCN1 in neutrophils and B cells and
underscored the need to study individual cell types.
In human eosinophils, voltage-gated proton channel
activity has been shown by detection of proton current
during ROS production [14,15]. Recently, it was docu-
mented that human eosinophils express HVCN1 [16].
However, although there are similarities between eosin-
ophils and neutrophils in regard to NADPH oxidase-
mediated ROS production, the location of NADPH
oxidase and the amount of ROS production mediated by
NADPH oxidase largely vary in these two cell types.
The majority of eosinophil NADPH oxidase is located
on the plasma membrane; thus, eosinophils primarily
generate extracellular ROS to kill nonphagocytosable
targets. In contrast, the vast majority of neutrophil
NADPH oxidase is located on the phagosome; thus,
neutrophils primarily generate intracellular ROS to kill
invading microorganisms [17]. Additionally, eosinophils
express more NADPH oxidase than neutrophils, thus
generating 3–6 times more superoxide than neutrophils
upon activation [18-20].
In the present study, we examined whether HVCN1
is expressed by mouse eosinophils and required
for ROS generation, eosinophil chemotaxis or other
functions. First, we identified that Hvcn1 mRNA is
expressed at a higher level in allergic lung and in
mouse eosinophils compared with neutrophils. Second,
we determined that, unlike in neutrophils, HVCN1 de-
ficiency does not affect calcium flux or migration of
mouse eosinophil. Finally, in the absence of HVCN1,
eosinophils undergo significantly increased cell death
upon PMA stimulation which is dependent on NADPH
oxidase activity. This increased activation-induced cell
death is likely caused by membrane depolarization and
cytosolic acidification in HVCN1-deficient eosinophils
following PMA stimulation. Collectively, our data dem-
onstrate that HVCN1 is important in regulating eo-
sinophil effector functions.Methods
Mice
Mice bearing a targeted disruption in the HVCN1 gene
(Hvcn1−/−, backcrossed eleven times onto the C57BL/6
background) were previously described [10]. In early
experiments, we used WT C57BL/6 mice as a control. In
later experiments, we used heterozygous-derived WT and
Hvcn1−/− lines (backcrossed twelve times onto the C57BL/
6 background). For each outcome (cell death, ROS pro-
duction, intracellular pH, membrane depolarization), the
difference between WT and Hvcn1−/− eosinophils was
similar irrespective of the type of control used. Mice used
for the studies were between 5 and 10 weeks old. All mice
were housed under specific pathogen-free conditions and
treated in accordance with institutional guidelines. Studies
were approved by the Cincinnati Children’s Hospital
Medical Center IACUC (protocol number 0D11085). Pain
and suffering were alleviated by anesthesia during proce-
dures and mice were sacrificed by CO2 inhalation.
Mouse model of allergic airway inflammation
Mice were challenged intranasally with Aspergillus
fumigatus as described [21]. Briefly, 100 μg (50 μl) of A.
fumigatus extract or 50 μl of normal saline solution
alone was applied to the mouse nasal cavity 3 times per
week for 3 weeks. 18 hours after the last challenge, mice
were sacrificed by CO2 inhalation. Bronchoalveolar lav-
age fluid (BALF) was collected and infiltrating cells dif-
ferentiated as previously described [22]. To isolate BALF
eosinophils, the infiltrating cells were adhered in a 6-
well plate at 37°C and 5% CO2 incubator. One hour
later, the nonadherent fraction containing ~85% purified
eosinophils was recovered. These BALF eosinophils and
whole lung tissue were used for total RNA extraction.
Microarray analysis
Microarray data for Hvcn1 expression are from a previ-
ously published data set [23]. Briefly, the genome-wide
mouse MOE430 2.0 GeneChip (Affymetrix, Santa Clara,
CA) was used. Average difference used in the present
study is a quantitative measure of the level of gene ex-
pression, calculated by taking the difference between
mismatch and perfect match of every probe pair and
averaging the differences over the entire probe set [21].
Eosinophil counting and culture
Peripheral blood eosinophils were counted by Discombe’s
staining [24]. BM-derived eosinophils were produced
according to the method described in reference [25] with
minor modifications. Briefly, BM progenitor cells were
collected from the femurs and tibiae by flushing the
opened bones with IMDM medium (Invitrogen). A hypo-
tonic lysis was performed to eliminate red blood cells.
Then the cells were cultured in six-well plates at 1×106/ml
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penicillin and 10 μg/ml streptomycin (Cellgro), 2 mM glu-
tamine (Invitrogen), and 50 μM 2-Mercaptoethanol
(Sigma-Aldrich) supplemented with 100 ng/ml stem cell
factor (SCF; PeproTech) and 100 ng/ml FLT3 ligand
(PeproTech) from days 0 to 4. On day 4, the medium was
replaced with fresh medium containing 10 ng/ml recom-
binant mouse IL-5 (R&D systems). From this point for-
ward, half of the medium was replaced every other day
with fresh medium containing IL-5, and the cell density
was maintained around 1×106/ml. On day 14, the cells
were harvested for in vitro experiments after flow
cytometric identification by CCR3-FITC (R&D Systems)
and Siglec-F-PE (BD Bioscience) staining as well as mor-
phological examination by cytospun slide staining with a
modified Giemsa preparation (Diff Quik). As expected,
more than 90% of harvested cells are eosinophils (data not
shown).
Neutrophil culture
BM-derived neutrophils were produced according to the
protocol described in [26] with minor modifications.
Briefly, BM progenitor cells were cultured in the IMDM
medium (Invitrogen) containing 10% FBS (Cambrex),
100 IU/ml penicillin and 10 μg/ml streptomycin
(Cellgro), 2 mM glutamine (Invitrogen), and 50 μM 2-
Mercaptoethanol (Sigma-Aldrich) supplemented with
100 ng/ml SCF (PeproTech) and 50 ng/ml granulocyte-
colony stimulating factor (PeproTech) from day 0 to 6.
After six days, SCF was withdrawn to arrest prolifera-
tion and induce further differentiation. On day 8, the
cells were harvested followed by flow cytometric identi-
fication by staining with Gr-1-APC (eBioscience). The
morphology of cytospun cells was determined by stain-
ing with a modified Giemsa preparation (Diff Quik).
Isolation of neutrophils and differential counting in
peritonitis model
4% thioglycollate medium was intraperitoneally injected
into WT and HVCN1-deficient mice to induce periton-
itis as described [27]. To isolate and count neutrophils,
the peritoneal lavage cells were collected 4 hours after
injection and adhered in a 6-well plate at 37°C and 5%
CO2 incubator. One hour later, the nonadherent fraction
containing 99% purified neutrophils was recovered and
counted. To count the numbers of infiltrating eosino-
phils in the peritonitis model, we collected peritoneal
lavage cells 48 hours after thioglycollate injection and
performed differential counting on Diff Quik-stained
cytospin slides.
Total RNA extraction and real-time RT-PCR
Total RNA from BM-derived eosinophils and neutro-
phils, BALF eosinophils, neutrophils isolated from theperitonitis model, and lung tissue from saline- or A.
fumigatus-challenged mice was extracted by TRIzol
(Invitrogen) as per the manufacturer’s instructions. One
microgram of RNA was subjected to DNase I treatment
(Qiagen) and reverse transcribed using the iScript™
cDNA Synthesis Kit (BioRad). Two microliters of cDNA
were subjected to real-time RT-PCR set up with iQ™
SYBR Green Supermix (BioRad) and primer sets for
mouse Hvcn1 (forward: 5′-TCGTGCTTGCTGAACTCC
TCCT; reverse: 5′-GGCAAAGCTCATGTAGTGGAAC
G) and Actb (β-actin gene) (forward: 5′-CGATGCCC
TGAGGCTCTTTTCC; reverse: 5′-CATCCTGTCAGC
AATGCCTGGG) separately. The relative expression
levels of Hvcn1 were normalized to the housekeeping
gene Actb.
Western blotting
In brief, protein lysates from mature WT and HVCN1-
deficient BM-derived eosinophils were prepared by
Laemmli sample buffer (BioRad) with protease inhibitor
cocktail (Roche) and sonication (4 rounds of 10 seconds
at 50% power). After blocking with 5% non-fat milk, the
nitrocellulose membrane was probed with the primary
rabbit polyclonal anti-HVCN1 (1:1000 dilution; AbCam)
overnight at 4°C and the secondary antibody (horserad-
ish peroxidase [HRP] conjugated-anti-rabbit, 1:1000 di-
lution; Cell Signaling) for 1 hour at room temperature.
Signals were detected on X-ray films using the enhanced
chemiluminescence method (ECL™ Western Blotting
Analysis System; GE Healthcare). Similar results were
obtained with rabbit polyclonal anti-HVCN1 (4234; kind
gift from Dr. I. Scott Ramsey).
Measurement of ROS production
For H2O2 measurements, mature BM-derived eosino-
phils were suspended in HBSS (Invitrogen) containing
25 μM Amplex Red (Invitrogen) and 0.05 U/ml HRP
and then seeded in a 96-well flat-bottom plate with
20,000 cells per well in a 100-μl final volume. After pre-
incubation for 10 minutes at 37°C, the inhibitors Zn2+
and diphenylene iodonium (DPI; Sigma) were added at
the indicated concentrations 10 minutes before the re-
cording. PMA (50 ng/ml) was added at time t = 0, and
fluorescence was measured at 590 nm on a microplate
reader (BioTek Synergy 2) every 10 minutes for 1 hour
at 37°C. Because phosphate in HBSS may chelate Zn2+, in
some experiments we tested phosphate-free Ringer’s solu-
tion (160mM NaCl, 5mM KCl, 2mM CaCl2, 1mM MgCl2,
5mM HEPES and 10mM glucose) in parallel with HBSS
[28]. Alternatively, to measure superoxide production, we
pre-incubated cells with 200 μM lucigenin (Invitrogen) in
HBSS for 30 minutes at 37°C in the presence or absence
of SOD (1000 U/ml); using the same microplate reader,
the chemiluminescence was measured every 10 minutes
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says, each condition was performed in triplicate. To meas-
ure the intracellular ROS, cells were pre-incubated with
1 μM dihydrorhodamine 123 (DHR 123; Invitrogen) for
30 minutes at 37°C. After subsequent PMA (50 ng/ml)
stimulation in the presence or absence of Zn2+ and DPI,
cells were subjected to flow cytometric analysis on FACS
Canto II (BD Bioscience) for analysis.
Membrane potential measurement
WT and Hvcn1−/− eosinophil plasma membrane potential
was determined using bis-(1,3-dibutylbarbituric acid)
trimethine oxonol (DiBAC4(3); Invitrogen), a potential-
sensitive bisoxonol fluorescent dye that enters depolarized
cells and exhibits enhanced fluorescence (Invitrogen).
Cells at 0.5×106/ml were pre-incubated with 600 nM
DiBAC4(3) in PBS at room temperature in the dark for
30 minutes. PMA (50 ng/ml) was added into the cell sus-
pension at time t = 0 and fluorescence was recorded
continuously by flow cytometry on Canto II (BD Bio-
science) for 12 minutes with excitation at 488 nm and
emission at 530 ± 30 nm.
Intracellular pH measurement
Intracellular pH was measured as described previously
[29] with minor modifications. Briefly, after stimulation
with PMA (50 ng/ml), BM-derived eosinophils were
suspended at 1×106 cells/ml in PBS and loaded with 5 μM
SNARF-4 AM (Invitrogen) for 30 minutes at 37°C in the
dark. After incubation, eosinophils were centrifuged and
resuspended in PBS. Emission fluorescence data were col-
lected by flow cytometer Canto II (BD Bioscience) at 580
nm and 640 nm using linear amplification, and the fluor-
escence ratio 640 nm / 580 nm was determined after gat-
ing out dead cells that failed to retain SNARF-4 AM
fluorescence. For calibration, 1 μg/ml nigericin was added
to the unstimulated cell suspension containing 140 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM α-D-glucose and
20 mM MES or Tris (pH 6.0-8.0). Intracellular pH of the
test samples was calculated according to the curve devel-
oped from the calibration solutions.
Assessment of cell viability
To determine the viability of BM-derived eosinophils
after PMA (50 ng/ml) stimulation, cells were harvested
and stained with 0.4% trypan blue solution at room
temperature for 3 minutes. The live (unstained) and
dead (stained) cells were then counted with a hemo-
cytometer under a light microscope. Alternatively, the
viability dye 7-AAD and APC-conjugated Annexin-V
(BD Bioscience) were utilized to stain the eosinophils
resuspended in Annexin-V binding buffer (BD Bio-
science). Samples were incubated at room temperaturefor 15 minutes and analyzed immediately on flow
cytometer Calibur I or Canto II (BD Bioscience).
Chemotaxis assay
The assay was performed in a transwell plate (Corning)
with a 5.0-μm pore size polycarbonate membrane. Five
hundred microliters of PBS containing recombinant
mouse Eotaxin-1 (mEotaxin-1 at 0, 1, 10, and 100 ng/ml,
PeproTech) were placed in the lower chamber. 1×106
BM-derived eosinophils in 100 microliters of PBS were
placed in the upper chamber. PBS in lower and upper
chamber was supplemented with 0.1% BSA and 1.0 mM
CaCl2. After 4-hour incubation at 37°C, cells migrating
to the lower chamber were harvested and counted in a
hemocytometer.
Intracellular calcium measurement
Eosinophils were loaded with 1 μM Fluo-4 AM
(Invitrogen), a calcium-sensitive fluorescent dye, in the
assay solution (HBSS containing 0.1% BSA and 1 mM
CaCl2) and incubated in the dark for 1 hour at 37°C.
Cells were washed twice and resuspended in the assay
solution at the density of 1×106 cells/ml. The fluores-
cence was recorded by flow cytometry on Canto II (BD
Bioscience) with excitation at 488 nm and emission at
520 nm prior to and immediately after adding mEotaxin-1
(1, 10, 100, and 300 ng/ml).
Statistical analysis
Student’s t-test and ANOVA were used for two-group
and multiple-group statistical analysis, respectively. The
software GraphPad Prism 5 was used for the analyses.
Results
Mouse eosinophils express HVCN1
Previous microarray analysis [23] identified significantly
increased lung expression of Hvcn1 in allergen (Aspergil-
lus)-challenged mice compared with saline-challenged
mice (Figure 1A). This increase was further confirmed by
real-time RT-PCR (Figure 1B) and could be explained by
the recruitment of HVCN1-expressing cells or by the
increased transcription of the Hvcn1 in structural or
recruited cells. As human eosinophils were recently
reported to express HVCN1 at the mRNA and protein
levels [16], we hypothesized that mouse eosinophils, as the
major inflammatory cells in the allergic lung, also express
HVCN1. By using real-time RT-PCR, we determined that
Hvcn1 is indeed expressed in mouse eosinophils not
only derived from BM progenitor cells but also isolated
from the lung tissue of allergen-challenged WT mice
(Figure 1C). Furthermore, we observed that Hvcn1 mRNA
expression level in BM-derived eosinophils is significantly
higher (3.3-fold on average) than that in BM-derived
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Figure 1 HVCN1 mRNA and protein expression levels in lung tissue and eosinophils. (A-B) The microarray (A) and real-time RT-PCR (B)
analyses show increased Hvcn1 levels in the lung tissue of the allergen (Aspergillus)-challenged mice compared to saline-challenged controls.
(C) Real-time RT-PCR analysis of Hvcn1 mRNA expression levels relative to housekeeping gene Actb (β-actin) in WT and HVCN1-deficient
eosinophils and neutrophils from the different source (seen in “Methods”). Data are expressed as mean ± SD of 4–6 mice per group. **, P < 0.01.
(D) Western blotting of HVCN1 in BM-derived eosinophils from WT and HVCN1-deficient mice, the representative of 4 experiments.
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average) than that in neutrophils isolated from a periton-
itis model (Figure 1C). As a control, our data show that
HVCN1 mRNA and protein expression level is markedly
reduced in HVCN1-deficient eosinophils compared to that
in WT eosinophils (Figure 1C and 1D). In order to explore
the function of HVCN1, BM-derived eosinophils from
WT and HVCN1-deficient mice were cultured in vitro.
We found no significant difference in the development of
BM-derived eosinophils from WT and HVCN1-deficient
mice with regard to their total cell numbers, morphology,
or co-expression of CCR3 and Siglec-F on the cell surface
(data not shown). Consistent with these findings, we ob-
served no significant difference in the number of periph-
eral blood eosinophils between WT and HVCN1-deficient
mice (data not shown), suggesting that HVCN1 deficiency
has no effect on eosinophil development in vivo.
HVCN1 is required for optimal ROS production by
eosinophils in response to PMA stimulation
We measured ROS production by WT and HVCN1-
deficient eosinophils following PMA stimulation. Asshown in Figure 2A and 2B, H2O2 production was re-
duced by 51% ± 3% (n = 4 experiments; P < 0.05) in
HVCN1-deficient eosinophils compared with WT eo-
sinophils following PMA stimulation, suggesting that
HVCN1 is required in part for ROS production by acti-
vated eosinophils. Consistent with a previous report
[28], the proton channel inhibitor Zn2+ reduced H2O2
production in a dose-dependent manner with complete
inhibition at the concentration of 1 mM. Moreover, DPI,
an inhibitor of flavoproteins including NADPH oxidase,
also completely inhibited H2O2 production in both WT
and HVCN1-deficient eosinophils (Figure 2A and 2B).
As a control to avoid the formation of zinc phosphate
in the H2O2 assay, phosphate-free Ringer’s solution
substituted HBSS in the parallel experiments and similar
results were obtained (data not shown). When ROS
was measured with an alternative method utilizing the
superoxide-specific probe lucigenin, we observed that
HVCN1-deficient eosinophils had significantly reduced
superoxide production compared to WT eosinophils as
early as 10 minutes after PMA stimulation (Figure 2C)
and that the average inhibition was 43 ± 4% (n = 4
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Figure 2 ROS production from WT and HVCN1-deficient eosinophils. (A) Time-dependent H2O2 production by WT and HVCN1-deficient (KO)
BM-derived eosinophils was measured using HBSS solution containing 25 μM Amplex Red and 0.05 U/ml HRP. Eosinophils were stimulated by
PMA (50 ng/ml) in the presence or absence of Zn2+ or DPI at the indicated concentrations. Data are representative of 4 separate experiments and
expressed as mean ± SD. The arrow indicates the addition of PMA at Time = 0. (B) Mean H2O2 production under the same conditions as (A) at
60 minutes following PMA stimulation. Data are expressed as the mean ± SD of 4 separate experiments done in triplicate. (C) Time-dependent
superoxide production by WT and HVCN1-deficient BM-derived eosinophils was determined using HBSS solution containing lucigenin (200 μM).
Eosinophils were stimulated by PMA (50 ng/ml) in the presence or absence of SOD (1000 U/ml). Data are representative of 4 separate
experiments and expressed as mean ± SD. The arrow indicates the addition of PMA at Time = 0. (D) Mean superoxide production under the
same conditions as (C) at 30 minutes after PMA stimulation. Data are expressed as the mean ± SD of 4 separate experiments done in triplicate.
*, P < 0.05; **, P < 0.01; n.s., not significant.
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of lucigenin, we used SOD in the assay. The addition of
SOD quenched the chemiluminescence induced by both
activated WT and HVCN1-deficient eosinophils to the
baseline level. Similar to BM-derived eosinophils, bron-
choalveolar lavage eosinophils from allergen-challenged
mice showed decreased ROS accumulation in HVCN1-
deficient cells (data not shown). Taken together, these
results indicate that HVCN1 is required for optimal ROS
release from eosinophils following PMA stimulation.
HVCN1 deficiency does not affect eosinophil migration
in vitro and in vivo
A previous study demonstrated that HVCN1-deficient
neutrophils have defective migration in response to the
chemoattractant fMIVIL in vitro secondary to impaired
calcium responses in HVCN1-deficient neutrophils [12].
We now extend these findings in vivo in a model of peri-
tonitis. Four hours after intraperitoneal injection of 4%thioglycollate medium, the infiltrating neutrophils in the
peritoneal cavity were collected and counted. The num-
ber of infiltrating neutrophils in HVCN1-deficient mice
was significantly reduced by 55% compared to that of
WT mice (Figure 3A, left), suggesting that HVCN1 defi-
ciency also impairs neutrophil migration in vivo. In
contrast, no significant difference was observed in the
number of recruited eosinophils between WT and
HVCN1-deficient mice 48 hours post injection (Figure 3A,
right), suggesting that HVCN1 deficiency does not affect
eosinophil migration in vivo. Furthermore, we did not ob-
serve any difference in the in vitro chemotactic migration
of WT and HVCN1-deficient eosinophils towards the
eosinophil-selective chemoattractant eotaxin-1 (Figure 3B).
Notably, WTand HVCN1-deficient eosinophils have simi-
lar viability following eotaxin-1 stimulation as determined
by trypan blue staining (data not shown). Since the previ-
ous study had suggested that lack of HVCN1 impedes the
migration of neutrophils by aborting physiological Ca2+
BA
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Figure 3 Chemotaxis and intracellular calcium flux in WT and HVCN1-deficient eosinophils. (A) The in vivo migration of neutrophils (left; n
= 3 experiments) and eosinophils (right; n = 4 experiments) was determined by morphologically counting the cells collected from the peritoneal
cavity of WT and HVCN1-deficient mice at the indicated time points following intraperitoneal injection of thioglycollate medium. Data are
expressed as the mean ± SD with mice from each experiment indicated by different symbols. (B) Transwell migration assay was performed to
compare the in vitro migration of WT and HVCN1-deficient eosinophils subjected to mEotaxin-1 at the indicated concentrations. The results are
expressed as migratory index by determining the ratio of total cell number under mEotaxin-1 attraction to total cell number without mEotaxin-1.
Data are representative of 3 experiments and expressed as mean ± SD. (C) Cytosolic Ca2+ response in WT and HVCN1-deficient eosinophils was
determined with intracellular fluorescence dye Fluo-4 AM in the presence of 1 mM extracellular Ca2+. Shown are the representative overlaid
traces out of 5 experiments for mEotaxin-1 (1-300ng/ml). The arrow indicates the time of mEotaxin-1 addition. The trace (blue: WT eosinophils;
red: HVCN1-deficient eosinophils) represents the average fluorescence intensity from cultured BM-derived eosinophils at the collection speed of
approximately 150 cells per second by flow cytometer Canto II. *, P < 0.05; **, P < 0.01; n.s., not significant.
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addition of mEotaxin-1. As shown in Figure 3C, we found
that there was comparable intracellular calcium accumula-
tion between WT and HVCN1-deficient eosinophils in
response to mEotaxin-1 (P=0.79 by paired t-test, n=5 ex-
periments). Collectively, these results suggest that HVCN1
deficiency does not affect mouse eosinophil migration
in vitro and in vivo.Enhanced cell death in HVCN1-deficient eosinophils
following PMA stimulation
During the course of our studies, we noticed differences
in viability of wild type and HVCN1-deficient cells.
Thus, we formally tested the hypothesis that HVCN1 de-
ficiency affects eosinophil viability. PMA-stimulated
HVCN1-deficient eosinophils underwent significantly in-
creased cell death compared with PMA-stimulated WT
A
Hvcn1+/+ Contro l Hvcn1-/- Contro l
Hvcn1+/+ PMA Hvcn1-/-  PMA








































































































































7-AAD - / Annexin-V + cells
Figure 4 Enhanced cell death in HVCN1-deficient eosinophils following PMA stimulation. (A) The viable eosinophils at the indicated time
points following PMA (50 ng/ml) stimulation were stained with trypan blue and counted. Data are expressed as the mean ± SD of 3 separate
experiments performed in duplicate. (B) Analysis of eosinophil apoptosis / cell death after four-hour PMA (50 ng/ml) stimulation by flow
cytometer Calibur I. Data are expressed as the mean ± SD of 4 separate experiments. (C) Kinetic analysis of eosinophil apoptosis / cell death
following PMA (50 ng/ml) stimulation. (D)Analysis of eosinophil apoptosis / cell death after four-hour anisomycin (10 μM) or anti-Fas antibody (1
μg/ml) stimulation by flow cytometer Canto II. Data are expressed as the mean ± SD of 3 separate experiments. *, P < 0.05; **, P < 0.01; n.s.,
not significant.
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able PMA-treated HVCN1-deficient cells compared to
viable PMA-treated WT cells was seen by 2 hours after
PMA stimulation; the difference increased even further
by 4 hours after stimulation, indicating that the number
of eosinophils undergoing cell death is increased and
that the kinetics of cell death are hastened for HVCN1-
deficient cells. We used flow cytometry with 7-AAD and
Annexin-V-APC staining to better understand the cell
death mechanisms. As shown in Figure 4B, PMA-
stimulated, HVCN1-deficient eosinophils were Annexin
V-positive and 7AAD-positive at 4 hours after PMA
stimulation. This finding was present at earlier time points
(1–2 hours, Figure 4C), suggesting that PMA-stimulated,
HVCN1-deficient eosinophils do not undergo characteris-
tic apoptotic cell death. In order to test the possibility that
HVCN1-deficient eosinophils are susceptible to an in-
creased rate of cell death irrespective of the stimulus, we
used several independent approaches to induce cell death
in WT and HVCN1-deficient eosinophils. There was no
difference between the two genotypes in cell viability in
unstimulated eosinophils undergoing spontaneous apop-
tosis or in eosinophils induced to undergo apoptosis
by IL-5 withdrawal or treatment with camptothecin,
anisomycin or anti-Fas antibodies (data not shown and
Figure 4D). Taken together, these data suggest that eosino-
phils lacking HVCN1 undergo enhanced cell death upon
activation with PMA.
Increased membrane depolarization and cytosolic
acidification in activated HVCN1-deficient eosinophils
The activation of NADPH oxidase can depolarize the
plasma membrane by transporting electrons to the extra-
cellular space [30] and simultaneously generate protons,
leading to cytosolic acidification [31]. Both membrane
depolarization and cytosolic acidification can cause cell
death [32,33], such as that shown in Figure 4. Under
physiological condition, proton efflux through the voltage-
gated proton channels provides the compensating charge,
thus preventing membrane depolarization and cytosolic
acidification as well. Thus, in order to first test the
hypothesis that PMA-induced cell death in HVCN1-
deficient eosinophils was dependent on the activation of
NADPH oxidase, we used the inhibitor DPI. When
HVCN1-deficient eosinophils were incubated with DPI
prior to PMA stimulation, cell death was prevented
(Figure 5A), which suggested that PMA-induced cell death
is NADPH oxidase-dependent. Second, we hypothesized
that lack of HVCN1 leads to membrane depolarization
and cytosolic acidification under conditions of NADPH
oxidase activity. Using the potential-sensitive probe
DiBAC4(3), we measured changes in membrane potential
during the activation of eosinophils. As shown in
Figure 5B, the membrane potential of unstimulated cellswas not affected by HVCN1 expression; however,
HVCN1-deficient eosinophils exhibited significantly larger
increase in membrane potential (depolarization) than WT
eosinophils after PMA stimulation.
Next, we performed intracellular pH measurement in
eosinophils by flow cytometry with pH indicator SNARF-
4 AM. The cytosolic pH of WT and HVCN1-deficient eo-
sinophils was similar (pH = ~7.3) in the absence of PMA
stimulation. However, HVCN1-deficient eosinophils had
remarkable cytosolic acidification (pH = ~6.5) as early as
30 minutes after PMA stimulation. This decreased cyto-
solic pH was maintained for at least 2 hours (Figure 5C).
In sharp contrast, WT eosinophils had only a minor de-
crease in cytosolic pH, which was never below pH 7.0
during the assay (Figure 5C). Notably, the addition of
1 mM Zn2+ induced the cytosolic acidification in PMA-
stimulated WT eosinophils to yield a similar pH level as
that of PMA-stimulated HVCN1-deficient eosinophils
(Figure 5D). Moreover, this additional Zn2+ induced in-
creased cell death in PMA-stimulated WT eosinophils
similar to that in PMA-stimulated HVCN1-deficient eo-
sinophils (Figure 5A), indicating that the inhibitory effect
of Zn2+ on proton channel activity mimics the HVCN1
deficiency on the eosinophils. Together, these data dem-
onstrate that proton channel HVCN1 prevents membrane
depolarization and cytosolic acidification during the acti-
vation of eosinophils.
Discussion
Recent studies have identified HVCN1 as the proton
channel responsible for charge compensation during
NADPH oxidase activity in neutrophils [10,12]. Add-
itionally, unexpected roles for HVCN1 were found in
neutrophils and B cells [12,13]. In this report, we used
WT and HVCN1-deficient eosinophils to determine the
function of HVCN1 in this cell type. Our studies re-
vealed several novel findings. First, we demonstrate that
Hvcn1 mRNA expression is increased in allergic lung
and is at a high basal level in eosinophils. Second, we
show that unlike mouse neutrophils, eosinophils do not
require HVCN1 for chemotaxis. Finally, we demonstrate
that HVCN1 is required for prevention of activation-
induced eosinophil cell death, likely because of the
membrane depolarization and cytosolic acidification that
occurs following PMA stimulation in the absence of
HVCN1.
In the present study, HVCN1-deficient eosinophils
demonstrated no migration defect, which is in contrast to
the results of HVCN1-deficient neutrophils. This can be
due to the different mechanism involving calcium mobi-
lization which controls numerous cellular functions
including cell migration. In neutrophils, Ca2+ entry occurs
largely across store-operated Ca2+ channels from the
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Figure 5 Increased membrane depolarization and cytosolic acidification in activated HVCN1-deficient eosinophils. (A) Flow cytometric
analysis of eosinophil cell death (7-AAD positive cells) after four-hour PMA (50 ng/ml) stimulation in the presence or absence of ZnCl2 (1 mM) or
DPI (10 μM). Data are expressed as the mean ± SD of 3 separate experiments. (B) Mean fluorescence intensity (MFI) of DiBAC4(3) in WT and
HVCN1-deficient BM-derived eosinophils. PMA evoked a larger depolarization in HVCN1-deficient than WT eosinophils. The vertical arrow indicates
the direction of depolarization. Data are representative of 5 separate experiments. (C) Intracellular pH in WT and HVCN1-deficient BM-derived
eosinophils was measured using the pH-sensitive dye SNARF-4 AM (5 μM) at the indicated time points after PMA (50 ng/ml) stimulation. Dead
cells were excluded by gating out cells that failed to retain SNARF-4 AM fluorescence. Data are expressed as the mean ± SD of 4 separate
experiments. (D) Intracellular pH in WT and HVCN1-deficient BM-derived eosinophils was measured 30 minutes after PMA (50 ng/ml) stimulation
in the presence or absence of ZnCl2 at the indicated concentrations. Data are expressed as the mean ± SD of 3 separate experiments. *, P < 0.05;
**, P < 0.01; n.s., not significant.
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extracellular Ca2+ into the cells and as a result impair mi-
gration ability, which has been shown in fMIVIL-activated
HVCN1-deficient neutrophils [12]. However, in human
eosinophils, several studies showed that pre-incubation
of eosinophils by intracellular calcium chelator 1,2-bis-
(o-aminophenoxy) ethane-N,N,N,N-tetraacetic acid acetoxy-
methyl ester (BAPTA-AM) dose-dependently prevented
calcium flux and the chemotactic response to platelet acti-
vating factor (PAF) and complement fragment 5a (C5a),but the depletion of extracellular calcium had no effect
[35,36], suggesting that intracellular calcium plays a more
important role in regulating eosinophil migration. The
other potential explanation (not mutually exclusive) for
the lack of effect of HVCN1 deficiency on eosinophil
migration comes from the finding that mEotaxin-1 does
not induce significant ROS generation by mouse eosino-
phils [37], which suggests that mEotaxin-1 does not
activate the NADPH oxidase and thus induce the mem-
brane depolarization in HVCN1-deficient eosinophils.
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sinophil migration.
In our study, we found that HVCN1 was required for
optimal ROS production. However, HVCN1-deficient
eosinophils still had ~50% ROS production retained
(Figure 2A-D). Similarly, HVCN1-deficient neutrophils
and B cells had ~30% ROS production retained [10,13],
suggesting that proton channels are not indispensible
even though they provide the bulk of compensating
charge in phagocytes [38] and that other channels might
facilitate charge compensation during ROS generation.
For instance, ClC-3 Cl-/H+ antiporter [39,40], CLIC-1 Cl
channels [41], TRPV1 nonselective cation channels [42],
SK2 and SK4 Ca2+-activated K+ channels [43], and Kv1.3
delayed rectifier K+ channels [44] have been proposed to
contribute to charge compensation in leukocytes. How-
ever, while these channels might provide charge com-
pensation, they would not alleviate the acidification. In
contrast, the sodium-hydrogen exchanger could extrude
the extra acid but could not compensate the extra
charge as this exchanger is not electrogenic [45,46].
Thus, HVCN1 is ideally suited to facilitate charge com-
pensation during ROS generation as it provides both
charge and acidity compensation.
HVCN1 was required for optimal ROS production by
eosinophils. Our study suggests two likely reasons for this
finding: (1) HVCN1-deficient eosinophils were more
depolarized than WT eosinophils after PMA stimulation
(Figure 5B), which was most likely caused by the lack of
compensating charge provided by proton channels. As a
result, the membrane depolarization hinders the flow of
electrons across the voltage-dependent flavocytochrome
[5,6], which is needed to reduce oxygen to superoxide.
(2) The deficiency of HVCN1 was also associated with a
substantial cytosolic acidification, which happened as
quickly as within 30 minutes after PMA stimulation
(Figure 5C). The activity of NADPH oxidase responsible
for ROS production, being optimal at intracellular pH 7.0-
7.5, could be decreased in this resulting acidic cytosol [47].
In addition to inhibiting NADPH oxidase activity,
membrane depolarization and cytosolic acidification may
be responsible for the observed activation-induced cell
death. However, we cannot exclude other possible rea-
sons. For instance, imbalance of osmolarity across the
membrane (presumably caused by K+ efflux) might also
account for the increased cell death of HVCN1-deficient
eosinophils following PMA stimulation.
In summary, our study identifies cell-specific roles for
HVCN1 in eosinophil respiratory burst and prevention
of activation-induced cell death but not eosinophil mi-
gration. These findings have implications for our under-
standing of the basic mechanism of eosinophil function,
as well as for targeting of eosinophils in eosinophil-
associated diseases.Conclusion
Eosinophils require proton channel HVCN1 for optimal
ROS generation and prevention of activation-induced
cell death.
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